7 followers
RT @AboutMyLupus: Open-label Phase II study of everolimus plus endocrine therapy in postmenopausal women with ER-positive and HER2-negative…
RT @AboutMyLupus: Open-label Phase II study of everolimus plus endocrine therapy in postmenopausal women with ER-positive and HER2-negative…
Open-label Phase II study of everolimus plus endocrine therapy in postmenopausal women with ER-positive and HER2-negative metastatic breast cancer (Chloe trial) https://t.co/2VmqXzJuKy https://t.co/PDKdw7Drwa